ID
35684
Beschrijving
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contains the Study Medication And Compliance Record form. It has to be filled in for each Visit. It also cntains the Dose reduction due to AE form. It has to be filled in for Week 12-48 and Follow-up.
Trefwoorden
Versies (1)
- 15-03-19 15-03-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
15 maart 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
Beschrijving
Study Medication And Compliance Record
Alias
- UMLS CUI-1
- C2734539
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1321605
Beschrijving
Week Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0439230
- UMLS CUI [1,2]
- C0237753
Beschrijving
Dose Level
Datatype
integer
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1]
- C3173309
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beschrijving
Number of tablets dispensed
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beschrijving
Number of tablets returned
Datatype
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Beschrijving
Dose Reductions Due to Adverse Experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Beschrijving
Week
Datatype
integer
Alias
- UMLS CUI [1]
- C0439230
Beschrijving
Dose Level
Datatype
integer
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1]
- C3173309
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beschrijving
Number of tablets dispensed
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beschrijving
Number of tablets returned
Datatype
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Similar models
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1321605 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Geen commentaren